Epsilon Healthcare Limited (ASX:EPN)

Market Cap	12.51M
Revenue (ttm)	6.13M -1.2%
Net Income	-6.12M
EPS	-0.02
Shares Out	379.10M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	244,377
Average Volume	282,190
Open	0.0320
Previous Close	0.0330
Day's Range	0.0320 - 0.0320
52-Week Range	0.0250 - 0.0400
Beta	0.73
RSI	50.73
Earnings Date	Feb 26, 2026

About Epsilon Healthcare

Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in two segments, Contract Development and Manufacturing Activities; and Telehealth Medical Practice Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturing of active pharmaceutical ingredients and finished formulations; and provision of pharmacy services and patient care. The company was formerly known as THC Global Group L...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2016
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: EPN

Financial Performance

In 2024, Epsilon Healthcare's revenue was 5.60 million, a decrease of -15.81% compared to the previous year's 6.65 million. Losses were -5.49 million, 403.6% more than in 2023.